Patents by Inventor Mark J. Kwakkenbos

Mark J. Kwakkenbos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9273118
    Abstract: The invention provides means and methods for modulating the occurrence of somatic hypermutations in antibody producing plasmablast-like B-cells.
    Type: Grant
    Filed: July 15, 2010
    Date of Patent: March 1, 2016
    Assignee: AIMM THERAPEUTICS B.V.
    Inventors: Tim Beaumont, Hergen Spits, Mark J. Kwakkenbos, Adrianus Q. Bakker
  • Publication number: 20120157662
    Abstract: The invention provides means and methods for modulating the occurrence of somatic hypermutations in antibody producing plasmablast-like B-cells.
    Type: Application
    Filed: July 15, 2010
    Publication date: June 21, 2012
    Inventors: Tim Beaumont, Hergen Spits, Mark J. Kwakkenbos, Adrianus Q. Bakker
  • Publication number: 20120157665
    Abstract: The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.
    Type: Application
    Filed: November 28, 2011
    Publication date: June 21, 2012
    Inventors: TIM BEAUMONT, MARK J. KWAKKENBOS, ERIC J. BROWN, JOHN H. MORISAKI, WOUTER L.W. HAZENBOS, SANJEEV MARIATHASAN, KIMBERLY KAJIHARA, YI XIA
  • Publication number: 20110020323
    Abstract: The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.
    Type: Application
    Filed: July 15, 2010
    Publication date: January 27, 2011
    Inventors: Tim BEAUMONT, Mark J. Kwakkenbos, Eric J. Brown, John H. Morisaki, Wouter L.W. Hazenbos, Sanjeev Mariathasan, Kimberly Kajihara, Yi Xia